Sangamo BioSciences Inc: Company Strategy, SWOT Analysis and 5-year Adjusted Financials
Scope
Report Highlights
Reasons to Purchase
Table of Contents
- Overview - page 1
- Catalyst - page 1
- Summary - page 1
- Table of Contents - page 2
- Table of figures - page 3
- Table of tables - page 4
- Company Structure - page 5
- Company Overview and Key Facts - page 5
- Business Description - page 6
- Landmark Products and Services - page 6
- ZFP Technology - page 6
- Landmark Products and Services - page 6
- History - page 8
- Company Financials - page 10
- Stock Market Performance - page 10
- P&L - page 11
- Balance Sheet - page 14
- Cash Flow - page 14
- Products & Services - page 15
- Pipeline Products - page 15
- In-house Pipeline - page 15
- SB-509 - page 15
- EW-A-401 - page 15
- ZFP TF - page 16
- Collaboration pipeline - page 16
- ZFN - page 16
- In-house Pipeline - page 15
- AC Forecast Sales - page 17
- Pipeline Products - page 15
- Competitors and Strategic Business Relationships - page 18
- Top Competitors - page 18
- Key Suppliers - page 19
- Key Clients - page 20
- Shareholding Structure - page 21
- Strategy - page 22
- Corporate Strategy - page 22
- SWOT Analysis - page 24
- Overview - page 24
- Strengths - page 25
- ZFP technology platform - page 25
- Partnerships - page 25
- Weaknesses - page 27
- Limited development capabilities - page 27
- Opportunities - page 28
- SB-509 - page 28
- Threats - page 29
- Lengthening drug approval process - page 29
- Value Chain Analysis - page 30
- Overview - page 30
- Product Development - page 30
- Scorecard - page 31
- Overview - page 31
- Scorecard Analysis - page 32
- Key Employees - page 33
- List of Key Employees - page 33
- Edward O Lanphier - page 33
- William G Gerber - page 33
- John W Larson - page 33
- Margaret A Liu - page 33
- Steven J Mento - page 33
- Michael C Wood - page 33
- H Ward Wolff - page 33
- David G Ichikawa - page 33
- Greg S Zante - page 33
- Dale Ando - page 33
- Philip D Gregory - page 33
- Key Employee Biographies - page 34
- Edward O Lanphier - page 34
- William G Gerber - page 34
- John W Larson - page 35
- Margaret A Liu - page 35
- Steven J Mento - page 36
- Michael C Wood - page 36
- H Ward Wolff - page 37
- David G Ichikawa - page 37
- Greg S Zante - page 38
- Dale Ando - page 38
- Philip D Gregory - page 39
- Ely Benaim - page 39
- Edward J Rebar - page 40
- Eric T Rhodes - page 40
- List of Key Employees - page 33
- Financial and Operational Overview - page 41
- Financial and Operational Overview - page 41
- Appendix - page 43
- Ask the analyst - page 43
- Datamonitor consulting - page 43
- Disclaimer - page 43
- List of Tables
- Table 1: Sangamo BioSciences - Key Facts - page 5
- Table 2: Sangamo BioSciences- Year-End Share Price and Market Capitalization, 2002-2006 ($) - page 10
- Table 3: Sangamo BioSciences- Key Events Impacting Share Price Performance - page 10
- Table 4: Sangamo BioSciences- Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) - page 11
- Table 5: Sangamo BioSciences- Operating Cost Ratio Analysis, 2002-2006 (% of total revenues) - page 13
- Table 6: Sangamo BioSciences- Balance Sheet, 2002-2006 ($ Mn) - page 14
- Table 7: Sangamo BioSciences- Cash Flow, 2002-2006 ($ Mn) - page 14
- Table 8: Sangamo BioSciences- In-house Pipeline Products - page 15
- Table 9: Sangamo BioSciences- Collaboration Pipeline Products - page 16
- Table 10: Sangamo BioSciences- Forecast Sales, 2006-2010 ($ Mn) - page 17
- Table 11: Sangamo BioSciences- Top Competitors - page 18
- Table 12: Sangamo BioSciences- Key Suppliers - page 19
- Table 13: Sangamo BioSciences- Key Clients - page 20
- Table 14: Sangamo BioSciences- Key Shareholders - page 21
- Table 15: Sangamo BioSciences- SWOT Analysis Summary - page 24
- Table 16: Sangamo BioSciences - Value Chain Analysis - page 30
- Table 17: Sangamo BioSciences- Scorecard - page 31
- Table 18: Sangamo BioSciences- Key Employees - page 33
- Table 19: Sangamo Biosciences - Financial and Operational Overview - page 41
- List of Figures
- Figure 1: Sangamo BioSciences- Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) - page 12
Other users found this report page using the following search terms: Sangamo BioSciences swot sangamo analysis biosciences mentos company zfp inc edward philip
If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.
Refund and Cancellation Policy: The descriptions of the products and services sold on LeadDiscovery.co.uk are as complete and accurate as possible, and customers are encouraged to read all available information about a product before placing an order. Due to the nature of the information being sold, orders for reports cannot be canceled.